Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
99. (WO2010144734) BENZONAPHTHYRIDINE-CONTAINING VACCINES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2010/144734 International Application No.: PCT/US2010/038216
Publication Date: 16.12.2010 International Filing Date: 10.06.2010
IPC:
A61K 39/39 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
39
characterised by the immunostimulating additives, e.g. chemical adjuvants
Applicants:
O'HAGAN, Derek, T. [US/US]; US (UsOnly)
SINGH, Manmohan [US/US]; US (UsOnly)
JAIN, Siddhartha [IN/US]; US (UsOnly)
KOMMAREDDY, Sushma [IN/US]; US (UsOnly)
NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-4056 Basel, CH (AllExceptUS)
Inventors:
O'HAGAN, Derek, T.; US
SINGH, Manmohan; US
JAIN, Siddhartha; US
KOMMAREDDY, Sushma; US
Agent:
Bonham, David, B.; Novartis Vaccines and Diagnostics, Inc. Corporate Intellectual Property X-100B P.O. Box Emeryville, CA 94662-8097, US
Priority Data:
61/185,95410.06.2009US
Title (EN) BENZONAPHTHYRIDINE-CONTAINING VACCINES
(FR) VACCINS CONTENANT DE LA BENZONAPHTYRIDINE
Abstract:
(EN) The invention provides, inter alia, immunogenic compositions that comprise (a) a first antigen, (b) polymeric particles and (c) a benzonaphthyridine compound, which compositions elicits an immune response when administered to a vertebrate subject. The invention also provides, inter alia, methods of producing immunogenic compositions and methods for using immunogenic compositions (e.g., for treatment), among other benefits.
(FR) L'invention porte, entre autres, sur des compositions immunogènes qui comprennent (a) un premier antigène, (b) des particules polymères et (c) un composé benzonaphtyridine, lesquelles compositions déclenchent une réponse immunitaire lorsqu'elles sont administrées à un sujet vertébré. L'invention porte également, entre autres, sur des procédés de production de compositions immunogènes et sur des procédés d'utilisation de compositions immunogènes (par exemple, pour un traitement), parmi d'autres avantages.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)